Also, in the final-EC group, higher HE4 levels were significantly linked to malignant characteristics such as deeper myometrial invasion, MELF (microcystic, elongated, and fragmented) positivity, larger tumor size, and diagnosis of intermediate-high-risk EC (Table 2). This evidence concerns the gene WFDC2 and neoplasm.